37: The Impact of Awareness Efforts in ALS
36: Zavegepant and the Gepant Class for Migraine Care
35: Highlights From the AAN Annual Meeting
34: Hope and the Huntington Disease Pipeline
33: Problem Recognition: Cerebral Palsy Diagnosis
32: The Gaps in Migraine Care for Women
31: The Pipeline Pendulum in Parkinson Disease
30: Cognitive Behaviorial Therapy for Insomnia
29: Developing A Seizure Action Plan
28: The Multiple Sclerosis Patient Journey
27: Short, Sudden, Strange, Similar Spells
26: Digital Approaches to Comprehensive Care in MS
25: 2020 Wrap Up: Silver Linings
24: Aducanumab and Alzheimer Disease Clinical Trials
23: Real-World Acute Migraine Care
22: Capitalizing on Collaboration in Neurology Care
21: How Social Isolation Can Affect Disease Severity
20: Taking Steps to Advance Sleep Care
19: The Vascular Implications of Alzheimer Disease
18: Preventing Tonic-Clonic Seizures in Refractory Epilepsy
17: The Metamorphosis of Migraine: Discovery and Development
16: Personalizing Our Approach to Medication Adherence in Parkinson Disease
15: A New Approval: The SMA Treatment Landscape
14: Trends in the Alzheimer Clinical Pipeline
13: Sequencing SNPs in Huntington Disease
12: Masculinity and Multiple Sclerosis
11: Exploring the Link Between Stroke and COVID-19
10: Neurology and COVID-19: Perspectives From the Front Line
9: Innovation in the Parkinson Disease Pipeline
8: Adapting Neurologic Care During the COVID-19 Pandemic
7: No Relief: Rising MS Drug Prices
6: Time Is Brain: Why EMS Transport Protocols Matter
5: Gut Bacteria and the Brain: An Evolving Role in Epilepsy
4: Only the Beginning: Advancing Migraine Treatment
3: Using Technology to Broaden Stroke Care
2: Alzheimer Disease Update: Is Amyloid Really Dead?
1: State of CBD: Not All Cannabidiol Is Created Equal